Emerging role of berbamine as an anti-cancer agent in systemic malignancies besides chronic myeloid leukemia

被引：9
|
作者：
Kapoor, Shailendra
机构：
[1] Zhejiang University,Department of Hematology, the Second Affiliated Hospital, School of Medicine
[2] Zhejiang University,Cancer Institute, School of Medicine
来源：
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B | 2012年 / 13卷 / 09期
关键词：
CELLS; APOPTOSIS; GROWTH;
D O I：
10.1631/jzus.B1200110
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：761 / 762
页数：2
相关论文
共 50 条
  • [31] Anti-cancer effects of ginsenoside compound k on pediatric acute myeloid leukemia cells
    Chen, Yan
    Xu, Yajing
    Zhu, Yan
    Li, Xiaolin
    CANCER CELL INTERNATIONAL, 2013, 13
  • [32] Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review
    Shaikh, Mohammad F.
    Morano, William F.
    Lee, John
    Gleeson, Elizabeth
    Babcock, Blake D.
    Michl, Josef
    Sarafraz-Yazdi, Ehsan
    Pincus, Matthew R.
    Bowne, Wilbur B.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2016, 46 (06): : 627 - 634
  • [33] The Role of Sea Cucumber Active Compound and Its Derivative as an Anti-Cancer Agent
    Wargasetia T.L.
    Permana S.
    Widodo
    Current Pharmacology Reports, 2018, 4 (1) : 27 - 32
  • [34] The impact of dietary polyphenols on the responsiveness of leukemia cells to an anti-cancer hypomethylating agent, decitabine (DAC)
    Boycott, Cayla
    Stefanska, Barbara
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (02) : 476 - 476
  • [35] Role of epigallochatechin-3-gallate as an anti-cancer agent in various cell lines
    Garcia, Marcela P.
    Fagnani, Danielle P.
    Penn, Lynn S.
    Xi, Jun
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [36] 30-day mortality associated with systemic anti-cancer therapy (SACT) in gastrointestinal malignancies: The Christie experience
    Marti, F. Marti
    McGurk, A.
    Alam, N.
    Bhatt, L.
    Braun, M.
    Hubner, R.
    Mansoor, W.
    McBain, C.
    McNamara, M.
    Mullamitha, S.
    Saunder, M.
    Sheikh, H.
    Thistlethwaite, F.
    Valle, J.
    Wilson, G.
    Hasan, J.
    ANNALS OF ONCOLOGY, 2018, 29
  • [37] Bexarotene and Its Potential Role in the Treatment of Neurological Disorders: Beyond Its Role as an Anti-Cancer Agent
    Kapoor, Shailendra
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (03) : 240 - 240
  • [38] POTENTIATION OF ANTI-CANCER AGENT CYTOTOXICITY AGAINST SENSITIVE AND RESISTANT AKR LEUKEMIA BY AMPHOTERICIN-B
    VALERIOTE, F
    MEDOFF, G
    DIECKMAN, J
    CANCER RESEARCH, 1979, 39 (06) : 2041 - 2045
  • [39] Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
    Qiao, Xiaohang
    van der Zanden, Sabina Y.
    Li, Xiaoyang
    Tan, Minkang
    Zhang, Yunxiang
    Song, Ji-Ying
    van Gelder, Merle A.
    Hamoen, Feija L.
    Janssen, Lennert
    Zuur, Charlotte L.
    Pang, Baoxu
    van Tellingen, Olaf
    Li, Junmin
    Neefjes, Jacques
    MOLECULAR CANCER, 2024, 23 (01)
  • [40] SENSITIZATION OF RESISTANT MYELOID-LEUKEMIA CLONE CELLS BY ANTI-CANCER DRUGS TO FACTOR-STIMULATING DIFFERENTIATION
    HAYASHI, M
    OKABE, J
    HOZUMI, M
    GANN, 1979, 70 (02): : 235 - 238
12345